Thornton & Ross take over

Thornton & Ross has acquired Oilatum, Savlon, Eurax, Polytar and Tixylix from GSK in a deal that is expected to be completed by August.

“These acquisitions demonstrate our determination to work with and support the pharmacy sector and our ambition to be the leading company in consumer health,” says Roger Scarlett-Smith, head and executive vice president of Thornton & Ross (pictured). 

“Our existing expertise in skincare and cough remedies puts us in a strong position to support and grow these acquisitions. We very much believe that the strong relationship we have in the pharmacy sector is crucial to our ongoing success. We look forward to giving these brands a new home and a bright future.”   

Comments (0)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.